Recombinant hepatitis B vaccine (Wuhan Institute of Biological Products)

重组乙型肝炎疫苗（CHO细胞）（武汉生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant hepatitis B vaccine (Wuhan Institute of Biological Products)
Drug Alias NamerhHBsAG vaccine(Wuhan Institute of Biological Products)Recombinant hepatitis B surface antigen vaccine(Wuhan Institute of Biological Products)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ07BC01
Related LinksN/A